Literature DB >> 7663784

Alveolar macrophage TNF-alpha release and BAL cell phenotypes in sarcoidosis.

L Zheng1, H Teschler, J Guzman, K Hübner, I Striz, U Costabel.   

Abstract

The aim of this study was to investigate the relationship between release of tumor necrosis factor-alpha (TNF-alpha) by alveolar macrophages (AM) and the phenotypic characteristics of bronchoalveolar lavage (BAL) cells in sarcoidosis. We studied the spontaneous release of TNF-alpha by AM in vitro and the phenotypic characteristics of freshly recovered BAL T-cells and AM in 31 individuals (13 with active sarcoidosis, nine with inactive sarcoidosis, and nine normal controls). TNF-alpha was measured by enzyme-linked immunosorbent assay (ELISA) in supernatants from unstimulated AM after 24 h culture. Phenotypic markers of BAL cells were determined by an immunocytochemical assay. AM of patients with active sarcoidosis released more TNF-alpha (1,355 +/- 133 pg/ml/ 10(6) AM/24 h) than those of the inactive group (651 +/- 142 pg/ml/10(6) AM/24 h) or the normal controls (425 +/- 121 pg/ml/10(6) AM/24 h), with p < 0.001 for both comparisons. The amount of TNF-alpha released correlated positively with the percentage expression of CD4 (r = 0.72) and CD25 (r = 0.70) by lymphocytes, and of CD14 (r = 0.63), VLA-4 (r = 0.59), FRD1 (r = 0.67) and 27E10 (r = 0.67) by AM, with p < 0.001 for all correlations. In conclusion, this relationship suggests that these antigens may be considered as cellular activation markers, and that some of these AM antigens may indirectly characterize the AM phenotype that is capable of producing TNF-alpha.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7663784     DOI: 10.1164/ajrccm.152.3.7663784

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  17 in total

Review 1.  Genetics of sarcoidosis: candidate genes and genome scans.

Authors:  Michael C Iannuzzi; Benjamin A Rybicki
Journal:  Proc Am Thorac Soc       Date:  2007-01

2.  Role of genetic polymorphisms in ACE and TNF-alpha gene in sarcoidosis: a meta-analysis.

Authors:  Igor Medica; Andrej Kastrin; Ales Maver; Borut Peterlin
Journal:  J Hum Genet       Date:  2007-09-04       Impact factor: 3.172

3.  Shed soluble ICAM-1 molecules in bronchoalveolar lavage cell supernatants and serum of patients with pulmonary sarcoidosis.

Authors:  I Bäumer; G Zissel; M Schlaak; J Müller-Quernheim
Journal:  Lung       Date:  1997       Impact factor: 2.584

4.  T-cell cytokines may control the balance of functionally distinct macrophage populations.

Authors:  V J Tormey; J Faul; C Leonard; C M Burke; A Dilmec; L W Poulter
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

5.  Tumour necrosis factor-alpha and leukotriene B(4) mediate the neutrophil migration in immune inflammation.

Authors:  C Canetti; J S Silva; S H Ferreira; F Q Cunha
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

6.  Adalimumab-induced pulmonary sarcoidosis not progressing upon treatment with etanercept.

Authors:  J H Jung; J-H Kim; G G Song
Journal:  Z Rheumatol       Date:  2017-05       Impact factor: 1.372

7.  Fluticasone propionate-induced regulation of the balance within macrophage subpopulations.

Authors:  V J Tormey; S Bernard; K Ivory; C M Burke; L W Poulter
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

8.  Analysis of regulatory T cell associated forkhead box P3 expression in the lungs of patients with sarcoidosis.

Authors:  F Idali; J Wahlström; C Müller-Suur; A Eklund; J Grunewald
Journal:  Clin Exp Immunol       Date:  2008-02-14       Impact factor: 4.330

Review 9.  Association of TNF polymorphisms with sarcoidosis, its prognosis and tumour necrosis factor (TNF)-alpha levels in Asian Indians.

Authors:  S Sharma; B Ghosh; S K Sharma
Journal:  Clin Exp Immunol       Date:  2007-12-06       Impact factor: 4.330

10.  Upregulation of neurokinin-1 receptor expression in the lungs of patients with sarcoidosis.

Authors:  Terence M O'Connor; Joseph O'Connell; Darren I O'Brien; Michael W Bennett; Triona Goode; Louise Burke; Charles P Bredin; Fergus Shanahan
Journal:  J Clin Immunol       Date:  2003-09       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.